A novel benzothiazine Ca2+ channel antagonist, semotiadil, inhibits cardiac L-type Ca2+ currents

This publication has 18 references indexed in Scilit:

• Pharmacological profile of semotiadil fumarate, a novel calcium antagonist, in rat experimental angina model
  British Journal of Pharmacology, 1995
• Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells
  Physiological Reviews, 1994
• Calcium Antagonistic and Binding Properties of Semotiadil (SD-3211), a Benzothiazine Derivative Assessed in Cerebral and Coronary Arteries
  Journal of Cardiovascular Pharmacology, 1992
• Cardiovascular characterization of SD-3211, a novel benzothiazine calcium channel blocker, in isolated rabbit hearts
  Life Sciences, 1991
• SD-3211, a Novel Benzothiazine Calcium Antagonist, Alone and in Combination with a Beta-Adrenoceptor Antagonist, Produces Antihypertensive Effects Without Affecting Heart Rate and Atrioventricular Conduction in Conscious Renal Hypertensive Dogs
  Journal of Cardiovascular Pharmacology, 1991
• Electrophysiological Properties of SD-3211, a Novel Putative Ca2+ Antagonist, in Isolated Guinea Pig and Rabbit Hearts
  Journal of Cardiovascular Pharmacology, 1990
• Influence of pHo on calcium channel block by amlodipine, a charged dihydropyridine compound. Implications for location of the dihydropyridine receptor.
  The Journal of general physiology, 1989
• Antiarrhythmic Agents: The Modulated Receptor Mechanism of Action of Sodium and Calcium Channel-Blocking Drugs
  Annual Review of Pharmacology and Toxicology, 1984
• Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells
  Nature, 1983
• Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches
  Pflügers Archiv - European Journal of Physiology, 1981